AQR CAPITAL MANAGEMENT LLC

Position in DSGN — Design Therapeutics, Inc.

CIK 1167557 Greenwich, CT

Position in DSGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,029,016

+$752,837 QoQ

Shares Held

71,114

+174.0% QoQ

Ownership

0.114%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#50

of 136 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. DSGN ranks #154 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,126,080	$702,155,918
2	INCY	Incyte Corp	5,320,901	$603,177,333
3	EXEL	Exelixis, Inc.	11,023,943	$599,812,735
4	JAZZ	Jazz Pharmaceuticals plc	1,522,568	$366,893,205
5	BMRN	Biomarin Pharmaceutical Inc	5,699,541	$326,127,732
6	VRTX	Vertex Pharmaceuticals Inc / Ma	616,170	$306,070,117
7	RVMD	Revolution Medicines, Inc.	1,295,450	$242,611,869
8	RPRX	Royalty Pharma plc	4,305,412	$241,404,446

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,029,016	71,114	+174.0%	Shares	Other	2026-08-14
2026-03-31	$276,179	25,957	+89.1%	Shares	Other	2026-05-15
2025-12-31	$128,784	13,730	+0.5%	Shares	Defined	2026-02-17
2025-09-30	$102,887	13,664	-52.4%	Shares	Defined	2025-11-14
2025-06-30	$96,804	28,726	-9.5%	Shares	Defined	2025-08-14
2025-03-31	$122,514	31,740	+6.3%	Shares	Other	2025-05-15
2024-12-31	$184,204	29,855	+176.8%	Shares	Other	2025-02-14
2024-09-30	$58,016	10,784	-2.7%	Shares	Other	2024-11-14
2024-06-30	$37,127	11,083	-5.7%	Shares	Other	2024-08-14
2024-03-31	$47,343	11,748	-79.1%	Shares	Other	2024-05-15
2023-12-31	$149,036	56,240	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.